Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-149,658
Closed -$9.44M 11
2016
Q3
$9.44M Buy
149,658
+32,498
+28% +$2.1M 0.5% 42
2016
Q2
$7.25M Sell
117,160
-70,721
-38% -$4.31M 0.39% 50
2016
Q1
$10.7M Buy
187,881
+28,357
+18% +$1.58M 0.57% 35
2015
Q4
$9.45M Sell
159,524
-21,512
-12% -$1.24M 0.55% 38
2015
Q3
$9.85M Sell
181,036
-3,428
-2% -$223K 0.62% 30
2015
Q2
$12.4M Sell
184,464
-3,123
-2% -$204K 0.66% 24
2015
Q1
$11M Buy
187,587
+8,949
+5% +$541K 0.59% 31
2014
Q4
$11.7M Buy
178,638
+21,244
+13% +$1.34M 0.63% 27
2014
Q3
$9.09M Sell
157,394
-30,931
-16% -$1.72M 0.51% 37
2014
Q2
$10.6M Buy
188,325
+30,069
+19% +$1.58M 0.59% 30
2014
Q1
$8.13M Sell
158,256
-25,807
-14% -$1.3M 0.46% 42
2013
Q4
$9.72M Buy
184,063
+48,000
+35% +$2.36M 0.5% 40
2013
Q3
$6.09M Buy
136,063
+509
+0.4% +$22.6K 0.35% 60
2013
Q2
$5.6M Buy
+135,554
New +$5.93M 0.34% 59

Other funds holding ABBV

Deere & Company's ABBV Position: Q4 2016 in Review

Deere & Company sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 149,658 shares — an estimated $9.44M sold.

Deere & Company first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $12.4M in Q2 2015. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Deere & Company reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 149,658 AbbVie shares in Q4 2016, an estimated $9.44M.
  • Deere & Company first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
  • Deere & Company's AbbVie position peaked at $12.4M in Q2 2015.
  • 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.